{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:53:58Z","timestamp":1785426838069,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.euo.2024.12.002","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:08:55Z","timestamp":1734394135000},"page":"164-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association Between Hypoglycemia Agents and Long-term Survival Outcomes for Patients with Non\u2013muscle-invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Gu\u00e9rin Immunotherapy"],"prefix":"10.1016","volume":"8","author":[{"given":"Kang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongda","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris Ho-Ming","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Ching-Ho","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Ka-Fung","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Fai","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy Yuen-Chun","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2024.12.002_b0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.euo.2024.12.002_b0010","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.eururo.2020.09.006","article-title":"Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita","volume":"78","author":"Teoh","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.12.002_b0015","unstructured":"International Agency for Research om Cancer. Cancer today. GLOBOCAN 2022: estimated number of prevalent cases. Geneva, Switzerland: World Health Organization; 2024."},{"key":"10.1016\/j.euo.2024.12.002_b0020","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","article-title":"Recurrence mechanisms of non-muscle-invasive bladder cancer \u2013 a clinical perspective","volume":"19","author":"Teoh","year":"2022","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2024.12.002_b0025","series-title":"EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS)","author":"Gontero","year":"2024"},{"key":"10.1016\/j.euo.2024.12.002_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2022.151975","article-title":"Synergistic effect of metformin and doxorubicin on the metastatic potential of T24 cells","volume":"125","author":"Mlicka","year":"2023","journal-title":"Acta Histochem"},{"key":"10.1016\/j.euo.2024.12.002_b0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11912-022-01344-7","article-title":"Use of antihyperglycemic drugs and risk of cancer in patients with diabetes","volume":"25","author":"S\u00f8ndergaard","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.euo.2024.12.002_b0040","doi-asserted-by":"crossref","first-page":"1128e","DOI":"10.1097\/PRS.0000000000011363","article-title":"Metformin eliminates lymphedema in mice by alleviating inflammation and fibrosis: implications for human therapy","volume":"154","author":"Wei","year":"2024","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.euo.2024.12.002_b0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11306-024-02096-0","article-title":"Identification of glucose-independent and reversible metabolic pathways associated with anti-proliferative effect of metformin in liver cancer cells","volume":"20","author":"Islam","year":"2024","journal-title":"Metabolomics"},{"key":"10.1016\/j.euo.2024.12.002_b0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12032-024-02306-8","article-title":"An effective treatment approach of liposomally encapsulated metformin in colon cancer","volume":"41","author":"Cetin","year":"2024","journal-title":"Med Oncol"},{"key":"10.1016\/j.euo.2024.12.002_b0055","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/bju.12448","article-title":"Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer","volume":"112","author":"Rieken","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2024.12.002_b0060","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3346\/jkms.2016.31.9.1464","article-title":"Impact of glycemic control and metformin use on the recurrence and progression of non-muscle invasive bladder cancer in patients with diabetes mellitus","volume":"31","author":"Ahn","year":"2016","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.euo.2024.12.002_b0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.11622\/smedj.2020121","article-title":"Beyond diabetes mellitus: role of metformin in non-muscle-invasive bladder cancer","volume":"63","author":"Wang","year":"2022","journal-title":"Singapore Med J"},{"key":"10.1016\/j.euo.2024.12.002_b0070","unstructured":"Charlson M. Charlson Comorbidity Index (CCI) Predicts 10-year survival in patients with multiple comorbidities. 2024. https:\/\/www.mdcalc.com\/calc\/3917\/charlson-comorbidity-index-cci."},{"key":"10.1016\/j.euo.2024.12.002_b0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.14740\/wjon1590","article-title":"Viability profiles of normal and cancer bladder cells with metformin, nitrate and adenosine monophosphate-activated protein kinase inhibitor","volume":"15","author":"Abdelmoaty","year":"2024","journal-title":"World J Oncol"},{"key":"10.1016\/j.euo.2024.12.002_b0080","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.euo.2024.12.002_b0085","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: historical overview","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.euo.2024.12.002_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155223","article-title":"Metformin: is it a drug for all reasons and diseases?","volume":"133","author":"Triggle","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.euo.2024.12.002_b0095","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","article-title":"Metformin: update on mechanisms of action and repurposing potential","volume":"19","author":"Foretz","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.euo.2024.12.002_b0100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211933120","article-title":"Metformin acts in the gut and induces gut-liver crosstalk","volume":"120","author":"Tobar","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.euo.2024.12.002_b0105","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature15766","article-title":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota","volume":"528","author":"Forslund","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.euo.2024.12.002_b0110","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1158\/1078-0432.CCR-20-0113","article-title":"Low-dose metformin reprograms the tumor immune microenvironment in human esophageal cancer: results of a phase II clinical trial","volume":"26","author":"Wang","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2024.12.002_b0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12894-023-01287-6","article-title":"Chronic prednisone, metformin, and nonsteroidal anti-inflammatory drug use and clinical outcome in a cohort of bladder cancer patients undergoing radical cystectomy in Qu\u00e9bec, Canada","volume":"23","author":"Wissing","year":"2023","journal-title":"BMC Urol"},{"key":"10.1016\/j.euo.2024.12.002_b0120","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1158\/1078-0432.CCR-18-3339","article-title":"Pre-surgical metformin in uterine malignancy (PREMIUM): a multi-center, randomized double-blind, placebo-controlled phase III trial","volume":"25","author":"Kitson","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2024.12.002_b0125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41392-021-00493-8","article-title":"Metformin targets clusterin to control lipogenesis and inhibit the growth of bladder cancer cells through SREBP-1c\/FASN axis","volume":"6","author":"Deng","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.euo.2024.12.002_b0130","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.3390\/molecules28186720","article-title":"Metformin-loaded chitosan hydrogels suppress bladder tumor growth in an orthotopic mouse model via intravesical administration","volume":"28","author":"Zhang","year":"2023","journal-title":"Molecules"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931124002840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931124002840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T21:43:15Z","timestamp":1739223795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931124002840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2588931124002840"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2024.12.002","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Hypoglycemia Agents and Long-term Survival Outcomes for Patients with Non\u2013muscle-invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Gu\u00e9rin Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2024.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}